NEWS & EVENTS

From 11 to 14 November 2024, the MEDICA in Düsseldorf, Germany, attracted over 6,000 renowned companies from around the world, making it a globally recognized comprehensive medical equipment exhibition. GenDx participated in MEDICA 2024 with its new products, including the GD-220 and GCP30 detection instruments, as well as dozens of amplification reagents and enzymes for amplification testing. The company showcased its innovative solutions in various segments such as biochemistry, molecular diagnostics, and POCT to the world, demonstrating its strong research and development capabilities and product competitiveness in the medical field.

On the exhibition day, major biotechnology and instrument companies gathered, with visitors arriving in a continuous stream, creating an unprecedented spectacle. GenDx stood out with its ultra-fast multi-plex detection technology, solving 15 respiratory tract infections and rapid POCT testing for sexually transmitted diseases. With the fastest nucleic acid testing results in the venue, requiring only 10 minutes for both speed and accuracy, GenDx showcased the "Chinese speed" to the world!

With its robust technical research and development capabilities and excellent product quality, GenDx has stayed ahead of the competition in the face of globalization, leveraging its globally leading Endonuleolytic Recycling Amplification (ERA) technology and 50 CE-registered products.

Through professional explanations and meticulous communications, GenDx successfully provided numerous visiting clients with a clear, comprehensive, and profound understanding of the ERA technology principles, product advantages, and practical applications. The company received recognition from over 100 partners from Europe, Africa, Southeast Asia, the Middle East, Latin America, and other regions, becoming one of the "stars" of the exhibition site.

Through continuous technical research and development and resource allocation, GenDx leverages its technical advantages and innovative capabilities in the field of molecular diagnostics, dedicated to developing rapid, accurate, and convenient detection technologies to make genetic technology accessible to the public. At this exhibition, GenDx showed the world its strong capabilities for the first time in a new look, earning praise from its partners.

As the owner of the globally proprietary intellectual property rights for Endonuleolytic Recycling Amplification (ERA) technology, GenDx has been committed to the industrialization of molecular POCT, aiming to continuously promote the advancement of in vitro diagnostic capabilities and levels, safeguarding public health and food safety. The company hopes to work with everyone to develop simple and rapid innovative product applications in more fields using the integrated nucleic acid rapid testing solution of ERA technology, contributing to solving more health, hygiene, and safety issues with GenDx's strength.

If you are interested in the one-step ERA technology and products, please contact us.